These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12459023)

  • 21. Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei.
    Balboni G; Salvadori S; Guerrini R; Bianchi C; Santagada V; Calliendo G; Bryant SD; Lazarus LH
    Peptides; 2000 Nov; 21(11):1663-71. PubMed ID: 11090920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
    Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore.
    Balboni G; Trapella C; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
    J Med Chem; 2009 Sep; 52(17):5556-9. PubMed ID: 19642675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).
    Salvadori S; Fiorini S; Trapella C; Porreca F; Davis P; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Balboni G
    Bioorg Med Chem; 2008 Mar; 16(6):3032-8. PubMed ID: 18178091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.
    Balboni G; Salvadori S; Dal Piaz A; Bortolotti F; Argazzi R; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Dec; 47(26):6541-6. PubMed ID: 15588089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.
    Ryu EK; Wu Z; Chen K; Lazarus LH; Marczak ED; Sasaki Y; Ambo A; Salvadori S; Ren C; Zhao H; Balboni G; Chen X
    J Med Chem; 2008 Mar; 51(6):1817-23. PubMed ID: 18311909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist.
    Lovekamp T; Cooper PS; Hardison J; Bryant SD; Guerrini R; Balboni G; Salvadori S; Lazarus LH
    Brain Res; 2001 May; 902(1):131-4. PubMed ID: 11376603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.
    Balboni G; Cocco MT; Salvadori S; Romagnoli R; Sasaki Y; Okada Y; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2005 Aug; 48(17):5608-11. PubMed ID: 16107162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationships.
    Shiotani K; Miyazaki A; Li T; Tsuda Y; Yokoi T; Ambo A; Sasaki Y; Bryant SD; Jinsmaa Y; Lazarus LH; Okada Y
    Med Chem; 2007 Nov; 3(6):583-98. PubMed ID: 18045209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
    Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
    FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
    Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.
    Ding J; Lemieux C; Chung NN; Schiller PW
    Chem Biol Drug Des; 2012 Feb; 79(2):186-93. PubMed ID: 22070627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides.
    Vázquez ME; Blanco JB; Salvadori S; Trapella C; Argazzi R; Bryant SD; Jinsmaa Y; Lazarus LH; Negri L; Giannini E; Lattanzi R; Colucci M; Balboni G
    J Med Chem; 2006 Jun; 49(12):3653-8. PubMed ID: 16759107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.
    Pagé D; McClory A; Mischki T; Schmidt R; Butterworth J; St-Onge S; Labarre M; Payza K; Brown W
    Bioorg Med Chem Lett; 2000 Jan; 10(2):167-70. PubMed ID: 10673103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds.
    Balboni G; Marzola E; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
    Bioorg Med Chem; 2010 Aug; 18(16):6024-30. PubMed ID: 20637637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif.
    Li T; Shiotani K; Miyazaki A; Fujita Y; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Lazarus LH; Okada Y
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5517-20. PubMed ID: 16183273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic.
    Salvadori S; Trapella C; Fiorini S; Negri L; Lattanzi R; Bryant SD; Jinsmaa Y; Lazarus LH; Balboni G
    Bioorg Med Chem; 2007 Nov; 15(22):6876-81. PubMed ID: 17851080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.